5 Most Profitable Value Stocks to Buy Right Now

3. Gilead Sciences Inc. (NASDAQ:GILD)

Gilead Sciences Inc. (NASDAQ:GILD) is one of the most profitable value stocks to buy right now. On April 7, Gilead Sciences announced its agreement to acquire Germany-based Tubulis GmbH for up to $5 billion. This transaction includes an upfront cash payment of $3.15 billion, with an additional $1.85 billion contingent on the achievement of specific milestones. This acquisition is part of a broader effort by Gilead to support its oncology pipeline as it faces declining sales of its COVID-19 treatment, Veklury, and looming patent expiries on other key products.

Through this deal, Gilead gains access to Tubulis’ portfolio of guided missiles, scientifically known as antibody-drug conjugates/ADCs. These experimental cancer treatments are designed to deliver chemotherapy directly to malignant cells, thereby minimizing damage to healthy tissue and reducing side effects. This move follows other recent high-value acquisitions, including the $7.8 billion purchase of Arcellx in February and the $2 billion acquisition of Ouro Medicines in March, as Gilead pivots toward high-growth areas like cancer and immune disorder treatments.

The acquisition reflects a continuing spree of deal-making intended to transform Gilead beyond its traditional dominance in virology. By integrating Tubulis’ ADC platform, Gilead Sciences Inc. (NASDAQ:GILD) aims to strengthen its position in the competitive oncology market. This investment aligns with the company’s recent history of aggressive expansion into cell therapy and precision medicine to secure long-term revenue streams in the face of shifting market dynamics.

Gilead Sciences Inc. (NASDAQ:GILD) is a drug manufacturer that develops medicines for unmet medical needs. The company provides treatments for HIV-1, chronic hepatitis C, primary biliary cholangitis, chronic hepatitis B, and serious invasive fungal infections. It also offers T-cell and CAR T-cell therapies for adult patients, intravenous injections, and treatments for COVID-19.